JSW Steel

The company has entered into a 50-50 joint venture
agreement with New Zealand-based National Steel Holdings Limited (NHSL) for
setting up scrap shredding facilities in India. This is a step forward in the
company’s endeavor to reduce its carbon footprint by setting a target of
achieving a 42% reduction in CO2 emissions intensity by the fiscal year 2030,
from the base year of 2005, the company said. NSHL is engaged in the business
of metal recycling, collection, and processing based in Auckland, New Zealand,
and has the relevant expertise and technical know-how concerning end-to-end
metal processing and recycling.

Also Read | Stocks to watch on Monday, August 22, 2022

One 97 Communications (Paytm)

Vijay Shekhar Sharma has been reappointed as the managing
director (MD) and chief executive officer (CEO) of One 97 Communications
Limited, the parent company of the digital payments app Paytm. About 99.67% of
shareholders voted in favor of Sharma’s reappointment. Sharma will continue to
serve as MD and CEO of the company for another five years, Paytm said in a statement.

Also Read | Trade Setup: Top 13 things to know before market opens on August 22, 2022

Adani Power

Gautam Adani-led Adani Power Limited has agreed to buy the
thermal power assets of DB Power Limited (DBPL) for nearly Rs 7,017 crore
enterprise valuation. Both sides signed an agreement for an all-cash deal. The
initial term of the MoU shall be till the completion of the acquisition on
October 31, 2022, which may be extended by mutual agreement. DB Power has 2
units of 600 MW each of thermal power in Janjgir-Champa district, Chattisgarh.

Also Read | Zomato apologises, pulls Hrithik Roshan-starrer Mahakal ad amid backlash

AstraZeneca Pharma India

The pharma company has received approval from the Drugs
Controller General of India to market its drug for the treatment of breast
cancer. The DCGI has approved Lynparza (Olaparib) as a monotherapy for the
treatment of adult patients with early breast cancer, who have previously been
treated with neoadjuvant or adjuvant chemotherapy. With the DCGI’s nod,
Lynparza is now approved in the US, EU, Japan, India, and several other
countries for the treatment of early-stage breast cancer, the company said.

Also Read | Apple security flaw let hackers gain complete control of devices

Gensol Engineering

The company has approved the acquisition of a majority
stake in Gensol Electric Vehicles, which will further acquire technical and
business know-how, patents, trademark, and brand name related to electric
vehicles from the US-based company. The company will raise Rs 140 crore from
promoters and non-promoters by issuing 13,51,030 equity shares on a
preferential basis at an issue price of Rs 1,036.25 per share.

Also Read | What is Delhi’s now-scrapped Excise policy?

Tejas Networks

The company has acquired the remaining balance of 93,571
equity shares of Saankhya Labs at a price of Rs 454.19 per equity share
amounting to consideration of Rs 4.25 crore through secondary purchase. With
the said transaction, Tejas Networks has acquired 62,51,496 equity shares or
64.4% stake in Saankhya for Rs 283.94 crore, on a fully diluted basis.

Also Read | What is RateGain? Air India’s choice to set global real-time pricing

Shilpa Medicare

The company’s wholly owned subsidiary Shilpa Biologicals
(SBPL) has completed the phase 3 human clinical studies of its first
biosimilar, the 100mg/ml high concentration (HC) Adalimumab biosimilar. It has
submitted the dossier to the CDSCO for review and grant of marketing or
manufacturing license – a first in India. The drug is expected to cater to
Rheumatoid Arthritis, Plaque Psoriasis, JIA, Psoriatic Arthritis, Ankylosing
Spondylitis, Ulcerative Colitis, Crohn’s disease, HS, and Uveitis markets –
diseases where India has the largest patient populations.

Also Read | How investment and savings strategies changed in last 30 years

Oriental Hotels

Nippon Life India Trustee sold 1.95 lakh equity shares or
0.1% stake in the company through open market transactions. With this, its
shareholding in the company reduced to 3.16%, down from 3.27%.